(Q71989492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

I Soubeyran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J Wafflart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

F Bonichon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

I de Mascarel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

M Trojani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

M Durand

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A Avril

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J M Coindre

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

119-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00665784

22 October 2019

exact match

0 references

cites work

Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis

1 reference

12 December 2020

pS2 protein and steroid hormone receptors in invasive breast carcinomas

1 reference

12 December 2020

Problems in dichotomizing continuous variables

1 reference

12 December 2020

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

1 reference

12 December 2020

Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7

1 reference

12 December 2020

Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa

1 reference

12 December 2020

Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

1 reference

12 December 2020

[Prognostic value of a continuous variable and an optimal cutoff point]

1 reference

12 December 2020

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.

1 reference

12 December 2020

pS2 expression and response to hormonal therapy in patients with advanced breast cancer

1 reference

12 December 2020

Estrogen receptors and breast cancer response to adrenalectomy

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response

1 reference

12 December 2020

Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours

1 reference

12 December 2020

Statistical aspects of prognostic factor studies in oncology

1 reference

12 December 2020

Prediction of relapse and survival in breast cancer patients by pS2 protein status

1 reference

12 December 2020

Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7)

1 reference

12 December 2020

Expression of the pNR-2/pS2 protein in diverse human epithelial tumours

1 reference

12 December 2020

pS2 is an independent factor of good prognosis in primary breast cancer

1 reference

12 December 2020

PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases

1 reference

12 December 2020

Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns

1 reference

12 December 2020

pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival

1 reference

12 December 2020

Monoclonal antibodies against native ant denatured forms of estrogen-induced breast cancer protein (BCEI/pS2) obtained by expression in Escherichia coli

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00665784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647329%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference